Close

Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c

November 10, 2022 10:03 AM EST

Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings